Supernus Announces FDA Approval of Qelbree®(Viloxazine) for the Treatment of ADHD in Adults
Summary : Qelbree (i.e. SPN-812) is a nonstimulant ADHD medication containing a serotonin norepinephrine modulating agent approved by the FDA to treat attention deficit…